0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Nuclear Medicine in the Evaluation of the Patient With Jaundice

Hirsch Handmaker, MD
JAMA. 1975;231(11):1172-1176. doi:10.1001/jama.1975.03240230046024.
Text Size: A A A
Published online

THE DEVELOPMENT of radiopharmaceuticals that localize within the hepatobiliary system has facilitated evaluation of many difficult clinical problems, particularly differentiation between surgical and medical jaundice.

In 1909, Abel and Rountree found that certain phenolphthalein dyes were excreted almost exclusively by the biliary system, and developed a clinical test of liver function based on measurement of fecal excretion of the dye. Sulfobromophthalein was later found to be superior to the other dyes for hepatic-clearance study, and in 1923 rose bengal was introduced by Delprat as a possible alternative. With use of fluorescent techniques, Mendeloff showed that stable rose bengal concentrated only in the polygonal cells and not in the reticuloendothelial cells. This knowledge led to Taplin's labeling of rose bengal with iodine 131, and permitted detection and imaging of the labeled dye as it was cleared from the blood, localized in the hepatocytes, and excreted into the bile en route to

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();